GENTHERM INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.33 USD | -2.20% |
|
-2.59% | -5.79% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 1.54B | Sales 2025 * | 1.67B | Capitalization | 1.56B |
|---|---|---|---|---|---|
| Net income 2024 * | 84M | Net income 2025 * | 112M | EV / Sales 2024 * | 1.05 x |
| Net Debt 2024 * | 57.31M | Net Debt 2025 * | 30.28M | EV / Sales 2025 * | 0.96 x |
| P/E ratio 2024 * |
18.7
x | P/E ratio 2025 * |
13.9
x | Employees | 14,504 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.43% |
More Fundamentals
* Assessed data
More news
Latest transcript on Gentherm Incorporated
More recommendations
More press releases
| 1 day | -2.20% | ||
| 1 week | -2.59% | ||
| Current month | -2.45% | ||
| 1 month | -1.32% | ||
| 3 months | +0.06% | ||
| 6 months | +3.14% | ||
| Current year | -5.79% |
1 week
49.21
52.00
1 month
49.1356.72
Current year
46.5162.93
1 year
38.2166.54
3 years
38.2199.00
5 years
27.2499.00
10 years
26.6099.00
| Managers | Title | Age | Since |
|---|---|---|---|
Phillip Eyler
CEO | Chief Executive Officer | 52 | 17-12-03 |
Matteo Anversa
DFI | Director of Finance/CFO | 52 | 18-12-31 |
Vishnu Sundaram
CTO | Chief Tech/Sci/R&D Officer | 41 | 23-09-04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Heinzmann
BRD | Director/Board Member | 60 | 20-08-10 |
| Chairman | 65 | 16-05-25 | |
Laura Kowalchik
BRD | Director/Board Member | 54 | Nov. 30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.16% | 43 M€ | +4.41% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-20 | 49.33 | -2.20% | 129,845 |
| 24-05-17 | 50.44 | -0.55% | 98,094 |
| 24-05-16 | 50.72 | -1.72% | 84,882 |
| 24-05-15 | 51.61 | +0.47% | 97,867 |
| 24-05-14 | 51.37 | +1.44% | 103,644 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotes
Gentherm Incorporated is a provider of thermal management and pneumatic comfort technologies for the automotive industry and medical industries. The Company operates through two segments: Automotive and Medical. The Automotive segment represents the design, development, manufacturing and sales of automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronic and software systems. Its automotive electronic and software systems include electronic control units for climate comfort systems, electronic control units. Its climate comfort systems include seat heaters, blowers, and thermoelectric devices. The Medical segment is comprised of the results from the patient temperature management business in the medical industry. The Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures.
Calendar
2024-07-24
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
49.33
USD
Average target price
69.2
USD
Spread / Average Target
+40.28%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.79% | 1.56B | |
| +22.52% | 48.71B | |
| -8.67% | 22.29B | |
| +17.48% | 19.12B | |
| +27.60% | 16.89B | |
| -4.01% | 15.06B | |
| -17.45% | 13.64B | |
| -19.42% | 13.52B | |
| +34.56% | 12.13B | |
| +38.85% | 10.92B |
- Stock Market
- Equities
- THRM Stock